3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
65
Other hematologic neoplasm
5
Classical hematology
5
Breast
5
Gynecologic
4
Gastrointestinal
4
Other
3
Genitourinary
3
Lymphoid
2
Head & Neck
2
Thoracic
1
Sarcoma
1
Plasma cell
1
NET
1
Myeloid
1
Endocrine
1
Dermatologic
1
CNS
1
Conditions
Neuroendocrine Tumors
3
Multiple Endocrine Neoplasia
3
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Radiation Injuries
1
Pituitary Neoplasms
1
Pinealoma
1
Oligodendroglioma
1
Non-resectable Metastatic Cancer of the Lung
1
Neuroendocrine Cervical Cancer
1
Neuroectodermal Tumors, Primitive
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Meningioma
1
Medulloblastoma
1
Growth Hormone-Secreting Pituitary Adenoma
1
Gliosarcoma
1
Glioma, Subependymal
1
Glioma
1
Glioblastoma
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Ependymoma
1
Craniopharyngioma
1
Colorectal Neoplasms
1
Choroid Plexus Neoplasms
1
Cholangiocarcinoma
1
Central Nervous System Neoplasms
1
Interventions
Everolimus
6
Sunitinib
4
Octreotide
4
Leucovorin
4
dabrafenib
3
Fluorouracil
3
3-Iodobenzylguanidine
3
trametinib
2
selpercatinib
2
lutetium Lu 177 dotatate
2
avelumab
2
alectinib
2
PM 01183
2
Oxaliplatin
2
Irinotecan
2
Fulvestrant
2
Drug Therapy
2
Doxorubicin
2
Cisplatin
2
trifluridine tipiracil drug combination
1
tipifarnib
1
telotristat ethyl
1
surufatinib
1
somapacitan
1
ribociclib
1
repotrectinib
1
pralsetinib
1
pentetreotide
1
pegfilgrastim
1
pasireotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Surveys and Questionnaires
×
Endocrine
×
Clear all
NCT07258810
2025-12-02
ETP-NET
Hospices Civils de Lyon
Not yet recruiting
100 enrolled